BioNTech vs RNAble
BioNTech vs RNAble, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and RNAble on 15/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 15/100
- agent readiness: 40/100 against 21/100
- domain rating: 74/100 against 30/100
- headcount: 5,128 against 2
- LinkedIn following: 295,812 against 107
RNAble
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BioNTech | RNAble |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | Developing novel RNA-targeting compounds for cancer and rare genetic diseases. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Life Sciences, RNA-Targeting, Oncology, RNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Platform |
| Founded | 2008 | 2021 |
| Headquarters | Mainz, Germany | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | BioNTech | RNAble |
|---|---|---|
| Employees | 5,128 | 2 |
| Headcount growthLast 12 months | Not published | -19.9% |
| Total funding | $975M | Not published |
| Latest round | Loan | Bootstrapped |
| LinkedIn followers | 295,812 | 107 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | RNAble |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 15/100 |
| Traction | 60/100 | 5/100 |
| Team | 70/100 | Not published |
| Search visibility | 35/100 | 24/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | RNAble |
|---|---|---|
| Hosting | Azure | Not detected |
| Analytics | Google Tag Manager | Not detected |
BioNTech vs RNAble: common questions
Which is better, BioNTech or RNAble?
On our 0-100 score BioNTech rates higher (66/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do BioNTech and RNAble compare on the numbers?
BioNTech leads on our overall score (66/100 against 15/100), agent readiness (40/100 against 21/100), domain rating (74/100 against 30/100), headcount (5,128 against 2), LinkedIn following (295,812 against 107).
Read the full BioNTech review and pricing or the RNAble review and pricing. You can also browse other BioNTech alternatives we track.